Development and Production of Parenteral Dosage Forms for Clinical Studies
Award Notice Posted
- Solicitation number
- N02-CM-77021-39
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Awarded
- to Ben Venue Laboratories, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- HHSN261200900006C Federal contract award
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
Notice text
The primary objective of this project is to develop and produce pharmaceutically acceptable parenteral dosage forms of promising new agents with activity against cancer. Data obtained from this contract may 1) be used to support IND applications submitted by the National Cancer Institute to the U.S. Food and Drug Administration as well as foreign agencies, 2) be provided to other NCI contractors engaged in large scale dosage form manufacture and analytical evaluation of these dosage forms and 3) be provided to physicians, pharmacists, nurses, and other medical personnel handling these products in a clinical setting.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Development and Production of Parenteral Dosage Forms for Clinical Trials | Award Notice |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity